Literature DB >> 21782347

Pathological personality traits among patients with absent, current, and remitted substance use disorders.

Christopher J Hopwood1, Leslie C Morey, Andrew E Skodol, Charles A Sanislow, Carlos M Grilo, Emily B Ansell, Thomas H McGlashan, John C Markowitz, Anthony Pinto, Shirley Yen, M Tracie Shea, John G Gunderson, Mary C Zanarini, Robert L Stout.   

Abstract

Personality traits may provide underlying risk factors for and/or sequelae to substance use disorders (SUDs). In this study Schedule for Nonadaptive and Adaptive Personality (SNAP) traits were compared in a clinical sample (N=704, age 18-45) with current, past, or no historical alcohol or non-alcohol substance use disorders (AUD and NASUD) as assessed by DSM-IV semi-structured interview. Results corroborated previous research in showing associations of negative temperament and disinhibition to SUD, highlighting the importance of these traits for indicating substance use proclivity or the chronic effects of substance use. Certain traits (manipulativeness, self-harm, disinhibition, and impulsivity for AUD, and disinhibition and exhibitionism for NASUD) were higher among individuals with current relative to past diagnoses, perhaps indicating concurrent effects of substance abuse on personality. The positive temperament characteristics detachment and entitlement distinguished AUDs and NASUDs, respectively, perhaps clarifying why this higher order trait tends to show limited relations to SUD generally. These findings suggest the importance of systematically integrating pathological and normative traits in reference to substance-related diagnosis.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21782347      PMCID: PMC3412532          DOI: 10.1016/j.addbeh.2011.06.006

Source DB:  PubMed          Journal:  Addict Behav        ISSN: 0306-4603            Impact factor:   3.913


  25 in total

1.  Personality and substance use disorders: II. Alcoholism versus drug use disorders.

Authors:  M McGue; W Slutske; W G Iacono
Journal:  J Consult Clin Psychol       Date:  1999-06

2.  Reasons for dropout from drug abuse treatment: symptoms, personality, and motivation.

Authors:  Samuel A Ball; Kathleen M Carroll; Monica Canning-Ball; Bruce J Rounsaville
Journal:  Addict Behav       Date:  2005-06-17       Impact factor: 3.913

Review 3.  The development of alcohol use disorders.

Authors:  Kenneth J Sher; Emily R Grekin; Natalie A Williams
Journal:  Annu Rev Clin Psychol       Date:  2005       Impact factor: 18.561

Review 4.  Externalizing pathology and the five-factor model: a meta-analysis of personality traits associated with antisocial personality disorder, substance use disorder, and their co-occurrence.

Authors:  Mark A Ruiz; Aaron L Pincus; John A Schinka
Journal:  J Pers Disord       Date:  2008-08

5.  The impact of borderline personality disorder on 12-month outcomes for the treatment of heroin dependence.

Authors:  Shane Darke; Joanne Ross; Anna Williamson; Maree Teesson
Journal:  Addiction       Date:  2005-08       Impact factor: 6.526

6.  Impulsivity and chronic stress are associated with amphetamine-induced striatal dopamine release.

Authors:  Lynn M Oswald; Dean F Wong; Yun Zhou; Anil Kumar; James Brasic; Mohab Alexander; Weiguo Ye; Hiroto Kuwabara; John Hilton; Gary S Wand
Journal:  Neuroimage       Date:  2007-03-12       Impact factor: 6.556

7.  A meta-analytic review of the relationships between the five-factor model and DSM-IV-TR personality disorders: a facet level analysis.

Authors:  Douglas B Samuel; Thomas A Widiger
Journal:  Clin Psychol Rev       Date:  2008-07-04

8.  Personality traits and the development of nicotine, alcohol, and illicit drug disorders: prospective links from adolescence to young adulthood.

Authors:  Irene J Elkins; Serena M King; Matt McGue; William G Iacono
Journal:  J Abnorm Psychol       Date:  2006-02

9.  Five-factor model personality traits associated with alcohol-related diagnoses in a clinical sample.

Authors:  Christopher J Hopwood; Leslie C Morey; Andrew E Skodol; Robert L Stout; Shirley Yen; Emily B Ansell; Carlos M Grilo; Thomas H McGlashan
Journal:  J Stud Alcohol Drugs       Date:  2007-05       Impact factor: 2.582

Review 10.  Impairments of brain and behavior: the neurological effects of alcohol.

Authors:  M Oscar-Berman; B Shagrin; D L Evert; C Epstein
Journal:  Alcohol Health Res World       Date:  1997
View more
  6 in total

1.  Refining the phenotype of borderline personality disorder: Diagnostic criteria and beyond.

Authors:  Michael N Hallquist; Paul A Pilkonis
Journal:  Personal Disord       Date:  2012-07

2.  The impact of non-concordant self-report of substance use in clinical trials research.

Authors:  C Brendan Clark; Cosmas M Zyambo; Ye Li; Karen L Cropsey
Journal:  Addict Behav       Date:  2016-02-17       Impact factor: 3.913

3.  Trait impulsivity is related to ventral ACC and amygdala activity during primary reward anticipation.

Authors:  Kara L Kerr; Jason A Avery; Joel C Barcalow; Scott E Moseman; Jerzy Bodurka; Patrick S F Bellgowan; W Kyle Simmons
Journal:  Soc Cogn Affect Neurosci       Date:  2014-02-12       Impact factor: 3.436

4.  Limitations of lifetime alcohol use disorder assessments: A criterion-validation study.

Authors:  Angela M Haeny; Andrew K Littlefield; Kenneth J Sher
Journal:  Addict Behav       Date:  2016-04-02       Impact factor: 3.913

5.  Addictions and Personality Traits: Impulsivity and Related Constructs.

Authors:  Marci R Mitchell; Marc N Potenza
Journal:  Curr Behav Neurosci Rep       Date:  2014-03-01

6.  Impulsivity in abstinent alcohol and polydrug dependence: a multidimensional approach.

Authors:  Eleanor M Taylor; Anna Murphy; Venkat Boyapati; Karen D Ersche; Remy Flechais; Shankar Kuchibatla; John McGonigle; Anotonio Metastasio; Liam Nestor; Csaba Orban; Fillippo Passetti; Louise Paterson; Dana Smith; John Suckling; Roger Tait; Anne R Lingford-Hughes; Trevor W Robbins; David J Nutt; J F William Deakin; Rebecca Elliott
Journal:  Psychopharmacology (Berl)       Date:  2016-02-25       Impact factor: 4.530

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.